VARDENAFIL HYDROCHLORIDE
| Brand name | STAXYN |
|---|---|
| Active ingredient | VARDENAFIL HYDROCHLORIDE |
| Strength | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | June 2010 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8613950 | December 2028 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.